PF PRISM CV FDA Approval NDA 021446

NDA 021446

PF PRISM CV

FDA Drug Application

Application #021446

Documents

Letter2006-03-01
Letter2007-07-05
Letter2009-05-04
Letter2010-01-06
Letter2010-10-19
Letter2011-06-29
Letter2012-06-21
Label2006-02-22
Label2009-05-12
Label2011-04-29
Label2011-07-07
Label2013-12-24
Review2005-07-18
Review2012-07-06
Healthcare Professional Sheet2005-11-30
Summary Review2012-07-06
Letter2005-01-11
Letter2006-03-01
Letter2006-11-06
Letter2009-05-04
Letter2011-04-29
Letter2011-04-29
Letter2011-08-26
Letter2013-12-26
Letter2016-03-11
Label2006-02-22
Label2007-06-27
Label2009-05-12
Label2010-01-08
Label2010-10-25
Label2011-04-29
Label2011-08-30
Label2012-06-21
Label2016-03-15
Label2016-12-22
Letter2016-12-23
Medication Guide2017-10-12
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Label2018-05-04
Medication Guide2018-05-04
Letter2018-05-08
Label2019-05-24
Medication Guide2019-05-24
Letter2019-05-24
Letter2020-04-06
Label2020-04-09

Application Sponsors

NDA 021446PF PRISM CV

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004
Prescription005
Prescription006
Prescription007
Prescription008

Application Products

001CAPSULE;ORAL25MG1LYRICAPREGABALIN
002CAPSULE;ORAL50MG1LYRICAPREGABALIN
003CAPSULE;ORAL75MG1LYRICAPREGABALIN
004CAPSULE;ORAL100MG1LYRICAPREGABALIN
005CAPSULE;ORAL150MG1LYRICAPREGABALIN
006CAPSULE;ORAL200MG1LYRICAPREGABALIN
007CAPSULE;ORAL225MG1LYRICAPREGABALIN
008CAPSULE;ORAL300MG1LYRICAPREGABALIN

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2004-12-30PRIORITY
LABELING; LabelingSUPPL2AP2006-02-17STANDARD
LABELING; LabelingSUPPL3AP2006-02-17STANDARD
LABELING; LabelingSUPPL6AP2006-10-27STANDARD
EFFICACY; EfficacySUPPL10AP2007-06-21PRIORITY
LABELING; LabelingSUPPL13AP2009-04-23901 REQUIRED
LABELING; LabelingSUPPL14AP2009-04-23STANDARD
LABELING; LabelingSUPPL18AP2010-01-04UNKNOWN
LABELING; LabelingSUPPL21AP2010-10-08UNKNOWN
LABELING; LabelingSUPPL23AP2011-04-26UNKNOWN
REMS; REMSSUPPL24AP2011-04-26N/A
LABELING; LabelingSUPPL25AP2011-08-24UNKNOWN
LABELING; LabelingSUPPL26AP2011-06-20STANDARD
EFFICACY; EfficacySUPPL28AP2012-06-20PRIORITY
LABELING; LabelingSUPPL29AP2013-12-23STANDARD
LABELING; LabelingSUPPL30AP2016-03-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL31AP2016-07-08PRIORITY
EFFICACY; EfficacySUPPL32AP2016-12-22STANDARD
EFFICACY; EfficacySUPPL35AP2018-05-03PRIORITY
EFFICACY; EfficacySUPPL36AP2019-05-23PRIORITY
LABELING; LabelingSUPPL40AP2020-04-03STANDARD

Submissions Property Types

SUPPL14Null7
SUPPL18Null6
SUPPL21Null7
SUPPL23Null7
SUPPL24Null4
SUPPL25Null6
SUPPL26Null6
SUPPL28Null15
SUPPL29Null6
SUPPL30Null6
SUPPL31Null0
SUPPL32Null15
SUPPL35Null6
SUPPL36Null7
SUPPL40Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB
005PrescriptionAB
006PrescriptionAB
007PrescriptionAB
008PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21446
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.